Sporicidal activity of ceragenin CSA-13 against Bacillus subtilis

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Piktel, Ewelina ^a   Pogoda, Katarzyna ^b   Roman, Maciej ^b   Niemirowicz, Katarzyna ^a   Tokajuk, Grayna ^a   Wróblewska, Marta ^c,d   Szynaka, Beata ^a   Kwiatek, Wojciech M ^b   Savage, Paul B ^e   Bucki, Robert ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b INSTITUTE OF NUCLEAR PHYSICS   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d Central Clinical Hospital in Warsaw   (Poland)

^e Brigham Young University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAGENIN CSA-13; DISINFECTANT AGENT; STEROID;

BACILLUS SUBTILIS; BACTERIAL SPORE; DRUG EFFECT; HUMAN; PATHOGENICITY; RAMAN SPECTROMETRY;

BACILLUS SUBTILIS; DISINFECTANTS; HUMANS; SPECTRUM ANALYSIS, RAMAN; SPORES, BACTERIAL; STEROIDS;

EID: 85015269366     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep44452     Document Type: Article

References (56)

1. Russell, A. D. Bacterial spores and chemical sporicidal agents. Clin Microbiol Rev 3, 99-119 (1990).
2. Nicholson, W. L., Munakata, N., Horneck, G., Melosh, H. J. & Setlow, P. Resistance of Bacillus endospores to extreme terrestrial and extraterrestrial environments. Microbiol Mol Biol Rev 64, 548-572 (2000).
3. Driks, A. Bacillus subtilis spore coat. Microbiol Mol Biol Rev 63, 1-20 (1999).
4. Nicholson, W. L., Schuerger, A. C. & Setlow, P. The solar UV environment and bacterial spore UV resistance: considerations for Earth-to-Mars transport by natural processes and human spaceflight. Mutat Res 571, 249-264, doi: 10.1016/j.mrfmmm.2004.10.012 (2005).
5. Lucking, G., Stoeckel, M., Atamer, Z., Hinrichs, J. & Ehling-Schulz, M. Characterization of aerobic spore-forming bacteria associated with industrial dairy processing environments and product spoilage. Int J Food Microbiol 166, 270-279, doi: 10.1016/j. ijfoodmicro.2013.07.004 (2013).
6. Depestel, D. D. & Aronoff, D. M. Epidemiology of Clostridium difficile infection. J Pharm Pract 26, 464-475, doi: 10.1177/0897190013499521 (2013).
7. Paredes-Sabja, D., Shen, A. & Sorg, J. A. Clostridium difficile spore biology: sporulation, germination, and spore structural proteins. Trends Microbiol 22, 406-416, doi: 10.1016/j.tim.2014.04.003 (2014).
8. Coleman, W. H., Chen, D., Li, Y. Q., Cowan, A. E. & Setlow, P. How moist heat kills spores of Bacillus subtilis. J Bacteriol 189, 8458-8466, doi: 10.1128/JB.01242-07 (2007).
9. Popham, D. L., Sengupta, S. & Setlow, P. Heat, hydrogen peroxide, and UV resistance of Bacillus subtilis spores with increased core water content and with or without major DNA-binding proteins. Appl Environ Microbiol 61, 3633-3638 (1995).
10. Bouillaut, L. et al. Effects of Surotomycin on Clostridium difficile Viability and Toxin Production In Vitro. Antimicrob Agents Chemother 59, 4199-4205, doi: 10.1128/AAC.00275-15 (2015).
11. Fairhead, H., Setlow, B. & Setlow, P. Prevention of DNA damage in spores and in vitro by small, acid-soluble proteins from Bacillus species. J Bacteriol 175, 1367-1374 (1993).
12. Magge, A. et al. Role of dipicolinic acid in the germination, stability, and viability of spores of Bacillus subtilis. J Bacteriol 190, 4798-4807, doi: 10.1128/JB.00477-08 (2008).
13. Leszczynska, K. et al. Antibacterial activity of the human host defence peptide LL-37 and selected synthetic cationic lipids against bacteria associated with oral and upper respiratory tract infections. J Antimicrob Chemother 68, 610-618, doi: 10.1093/jac/dks434 (2013).
14. Leszczynska, K. et al. Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infections. J Appl Microbiol 110, 229-238, doi: 10.1111/j.1365-2672.2010.04874.x (2011).
15. Byfield, F. J. et al. Cathelicidin LL-37 increases lung epithelial cell stiffness, decreases transepithelial permeability, and prevents epithelial invasion by Pseudomonas aeruginosa. J Immunol 187, 6402-6409, doi: 10.4049/jimmunol.1102185 (2011).
16. Wnorowska, U. et al. Bactericidal activity of cathelicidin LL-37 and select cationic lipids against the hypervirulent P. aeruginosa strain LESB58. Antimicrob Agents Chemother, doi: 10.1128/AAC.00421-15 (2015).
17. Surel, U., Niemirowicz, K., Marzec, M., Savage, P. B. & Bucki, R. Ceragenins - a new weapon to fight multidrug resistant bacterial infections. Studia Medyczne 30, 207-213 (2014).
18. Wnorowska, U. et al. Extracellular DNA as an essential component and therapeutic target of microbial biofilm. Studia Medyczne 31, 132-138 (2015).
19. Leszczynska, K. et al. Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice. BMC Microbiol 9, 187, doi: 10.1186/1471-2180-9-187 (2009).
20. Bucki, R. & Janmey, P. A. Interaction of the gelsolin-derived antibacterial PBP 10 peptide with lipid bilayers and cell membranes. Antimicrob Agents Chemother 50, 2932-2940, doi: 10.1128/AAC.00134-06 (2006).
21. Howell, M. D. et al. Ceragenins: a class of antiviral compounds to treat orthopox infections. J Invest Dermatol 129, 2668-2675, doi: 10.1038/jid.2009.120 (2009).
22. Niemirowicz, K. et al. Bactericidal activity and biocompatibility of ceragenin-coated magnetic nanoparticles. J Nanobiotechnology 13, 32, doi: 10.1186/s12951-015-0093-5 (2015).
23. Aldape, M. J., Heeney, D. D., Bryant, A. E. & Stevens, D. L. Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile. J Antimicrob Chemother 70, 153-159, doi: 10.1093/jac/dku325 (2015).
24. Zeigler, D. R. et al. The origins of 168, W23, and other Bacillus subtilis legacy strains. J Bacteriol 190, 6983-6995, doi: 10.1128/ JB.00722-08 (2008).
25. Setlow, P. Mechanisms which contribute to the long-term survival of spores of Bacillus species. Soc Appl Bacteriol Symp Ser 23, 49S-60S (1994).
26. Savage, P. B., Li, C., Taotafa, U., Ding, B. & Guan, Q. Antibacterial properties of cationic steroid antibiotics. FEMS Microbiol Lett 217, 1-7 (2002).
27. Lai, X. Z. et al. Ceragenins: cholic acid-based mimics of antimicrobial peptides. Acc Chem Res 41, 1233-1240, doi: 10.1021/ ar700270t (2008).
28. Saha, S., Savage, P. B. & Bal, M. Enhancement of the efficacy of erythromycin in multiple antibiotic-resistant gram-negative bacterial pathogens. J Appl Microbiol 105, 822-828, doi: 10.1111/j.1365-2672.2008.03820.x (2008).
29. Magge, A., Setlow, B., Cowan, A. E. & Setlow, P. Analysis of dye binding by and membrane potential in spores of Bacillus species. J Appl Microbiol 106, 814-824, doi: 10.1111/j.1365-2672.2008.04048.x (2009).
30. Setlow, P. Spores of Bacillus subtilis: their resistance to and killing by radiation, heat and chemicals. J Appl Microbiol 101, 514-525, doi: 10.1111/j.1365-2672.2005.02736.x (2006).
31. Setlow, B., Atluri, S., Kitchel, R., Koziol-Dube, K. & Setlow, P. Role of dipicolinic acid in resistance and stability of spores of Bacillus subtilis with or without DNA-protective alpha/beta-type small acid-soluble proteins. J Bacteriol 188, 3740-3747, doi: 10.1128/ JB.00212-06 (2006).
32. Setlow, B., McGinnis, K. A., Ragkousi, K. & Setlow, P. Effects of major spore-specific DNA binding proteins on Bacillus subtilis sporulation and spore properties. J Bacteriol 182, 6906-6912 (2000).
33. Cortezzo, D. E. & Setlow, P. Analysis of factors that influence the sensitivity of spores of Bacillus subtilis to DNA damaging chemicals. J Appl Microbiol 98, 606-617, doi: 10.1111/j.1365-2672.2004.02495.x (2005).
34. Genest, P. C., Setlow, B., Melly, E. & Setlow, P. Killing of spores of Bacillus subtilis by peroxynitrite appears to be caused by membrane damage. Microbiology 148, 307-314 (2002).
35. Melly, E., Cowan, A. E. & Setlow, P. Studies on the mechanism of killing of Bacillus subtilis spores by hydrogen peroxide. J Appl Microbiol 93, 316-325 (2002).
36. Henriques, A. O., Melsen, L. R. & Moran, C. P. Involvement of superoxide dismutase in spore coat assembly in Bacillus subtilis. J Bacteriol 180, 2285-2291 (1998).
37. Setlow, B. et al. Mechanisms of killing spores of Bacillus subtilis by acid, alkali and ethanol. J Appl Microbiol 92, 362-375 (2002).
38. Ghosh, S. & Setlow, P. Isolation and characterization of superdormant spores of Bacillus species. J Bacteriol 191, 1787-1797, doi: 10.1128/JB.01668-08 (2009).
39. Koch, A. L. The pH in the neighborhood of membranes generating a protonmotive force. J Theor Biol 120, 73-84 (1986).
40. Kemper, M. A., Urrutia, M. M., Beveridge, T. J., Koch, A. L. & Doyle, R. J. Proton motive force may regulate cell wall-associated enzymes of Bacillus subtilis. J Bacteriol 175, 5690-5696 (1993).
41. Paidhungat, M., Setlow, B., Driks, A. & Setlow, P. Characterization of spores of Bacillus subtilis which lack dipicolinic acid. J Bacteriol 182, 5505-5512 (2000).
42. del Carmen Huesca Espitia, L., Caley, C., Bagyan, I. & Setlow, P. Base-change mutations induced by various treatments of Bacillus subtilis spores with and without DNA protective small, acid-soluble spore proteins. Mutat Res 503, 77-84 (2002).
43. Balassa, G., Milhaud, P., Raulet, E., Silva, M. T. & Sousa, J. C. A Bacillus subtilis mutant requiring dipicolinic acid for the development of heat-resistant spores. J Gen Microbiol 110, 365-379, doi: 10.1099/00221287-110-2-365 (1979).
44. Hanson, R. S., Curry, M. V., Garner, J. V. & Halvorson, H. O. Mutants of Bacillus cereus strain T that produce thermoresistant spores lacking dipicolinate and have low levels of calcium. Can J Microbiol 18, 1139-1143 (1972).
45. Russell, A. D. & Loosemore, M. Effect of phenol on Bacillus subtilis spores at elevated temperatures. Appl Microbiol 12, 403-406 (1964).
46. Paidhungat, M. & Setlow, P. Role of ger proteins in nutrient and nonnutrient triggering of spore germination in Bacillus subtilis. J Bacteriol 182, 2513-2519 (2000).
47. Setlow, P. Germination of spores of Bacillus species: what we know and do not know. J Bacteriol 196, 1297-1305, doi: 10.1128/ JB.01455-13 (2014).
48. Niemirowicz, K. et al. Magnetic nanoparticles enhance the anticancer activity of cathelicidin LL-37 peptide against colon cancer cells. Int J Nanomedicine 10, 3843-3853, doi: 10.2147/IJN.S76104 (2015).
49. Bozkurt-Guzel, C., Savage, P. B. & Gerceker, A. A. In vitro activities of the novel ceragenin CSA-13, alone or in combination with colistin, tobramycin, and ciprofloxacin, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients. Chemotherapy 57, 505-510, doi: 10.1159/000335588 (2011).
50. Kuroda, K. et al. Ceragenin CSA-13 induces cell cycle arrest and antiproliferative effects in wild-type and p53 null mutant HCT116 colon cancer cells. Anti-cancer drugs 24, 826-834, doi: 10.1097/CAD.0b013e3283634dd0 (2013).
51. Piktel, E. et al. The Role of Cathelicidin LL-37 in Cancer Development. Arch Immunol Ther Exp (Warsz) 64, 33-46, doi: 10.1007/ s00005-015-0359-5 (2016).
52. Swiecicka, I., Fiedoruk, K. & Bednarz, G. The occurrence and properties of Bacillus thuringiensis isolated from free-living animals. Lett Appl Microbiol 34, 194-198 (2002).
53. Vaerewijck, M. J. et al. Occurrence of Bacillus sporothermodurans and other aerobic spore-forming species in feed concentrate for dairy cattle. J Appl Microbiol 91, 1074-1084 (2001).
54. Xi-Yang. Studies on the impact of probiotic bacteria on enteric microbial diversity and immune response. University of Wollongong (2006).
55. Zhang, P., Setlow, P. & Li, Y. Characterization of single heat-activated Bacillus spores using laser tweezers Raman spectroscopy. Opt Express 17, 16480-16491 (2009).
56. Maesaki, S., Marichal, P., Vanden Bossche, H., Sanglard, D. & Kohno, S. Rhodamine 6G efflux for the detection of CDR1- overexpressing azole-resistant Candida albicans strains. The Journal of antimicrobial chemotherapy 44, 27-31 (1999).